Worldwide Burn Care Centers Industry to 2028 - Players Include Convatec Healthcare, Coloplast & Acelity Among Others
May 04, 2021 04:33 ET
|
Research and Markets
Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "Burn Care Centers Market Share, Size, Trends, Industry Analysis Report, By Facility Type, By Treatment Type; By Severity; By Service Type; By Regions;...
Global Burn Care Market (2021 to 2026) - Featuring 3M, Cardinal Health and Medline Industries Among Others
March 31, 2021 05:58 ET
|
Research and Markets
Dublin, March 31, 2021 (GLOBE NEWSWIRE) -- The "Global Burn Care Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global burn care market is...
RenovaCare Announces Organizational Changes and Appointment of New Officers
March 30, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the...
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
February 25, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference
January 08, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Chairman Discusses 2020 Highlights and Provides 2021 Outlook
December 22, 2020 08:00 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare Awarded New Patents Allowing Greater Versatility of SkinGun™; Sterility in Field Environments; Spray Solutions to Now Include Targeted Cells, Drugs or Hormones
November 19, 2020 08:15 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
Global Surgical Sealants and Adhesives Market to 2025 by Product, Indication, Application, End User
November 19, 2020 03:43 ET
|
Research and Markets
Dublin, Nov. 19, 2020 (GLOBE NEWSWIRE) -- The "Surgical Sealants and Adhesives Market by Product (Natural (Fibrin, Collagen, Gelatin), Synthetic (Hydrogel)), Indication (Tissue Sealing, Tissue...
RenovaCare to Commence Investor Business and Financial Presentations; Webcast on October 29, 2020
October 22, 2020 16:35 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Oct. 22, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
August 11, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...